“…The plant expression platforms have many merits compared to other platforms, such as lower cost; easier scaling-up; easier storage; easier to find employees with professional skills and experiences in plant culture, harvesting and processing; sufficient post-translational modifications and less risks of biosecurity. There have been numerous reviews summarized in the field [ 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 ]. Many types of recombinant proteins, including industrial proteins (e.g., cellulase) [ 42 , 43 ], biopolymers (e.g., spidroin) [ 44 ], and pharmaceutical proteins (e.g., EGF) [ 25 ] have been reported to be successfully expressed in plants.…”